Data protection Impressum

Healthcare

Undae Science, a spin-off of the University of Lausanne, has raised CHF 1.15 million from 41 investors as part of its seed round, to complete the industrialization of its Noctae sleep platform.

Undae Science raises CHF 1.15 million to industrialize its home sleep-monitoring platform

9 November 2026

Barcelona-based STE Pharmaceuticals plans to convert the former Analytecon plant in Couvet, in the canton of Neuchâtel, into a production site and an R&D department, with completion targeted for 2032.

Catalan pharmaceutical group STE Pharmaceuticals to establish production and R&D in Couvet

3 November 2026

Built with partners in Zurich and Geneva, spora is a spatial proteomics atlas that EPFL describes as the world's largest freely available collection of its kind, designed to speed up AI research on how diseases develop.

EPFL releases a free tissue atlas to help AI understand cancer

2 November 2026

The Foundation for Innovation and Technology (FIT) is supporting three start-ups working on an osteoporosis treatment, faster tissue analysis during cancer surgery and vineyard monitoring.

Biodelphis Therapeutics, PolaSight and Swiss Soil each receive a CHF 100,000 Tech Seed loan

2 November 2026

Alcon, the eye care company headquartered in Geneva, has acquired US biotech Neurotech Pharmaceuticals for USD 550 million in cash, plus potential additional payments tied to milestones.

Alcon has acquired Neurotech for USD 550 million

26 October 2026

Switzerland's sports tech sector counts 402 companies, an estimated CHF 8 billion in revenue and about 17,000 jobs, according to the first Swiss SportsTech Report. Vaud and Bern are among the three cantons that concentrate about half of the companies.

First Swiss SportsTech Report maps a CHF 8 billion sector with Vaud and Bern among its main hubs

26 October 2026

Distalmotion, a medtech company based in Lausanne, has secured a senior secured term loan facility of up to USD 70 million from Perceptive Advisors to accelerate the US expansion of its DEXTER robotic surgery system in ambulatory surgery centers.

Distalmotion secures up to USD 70 million to expand its DEXTER surgical robot in the US

26 October 2026

Hilo, a Neuchâtel-based health tech company and CSEM spin-off, has been named to TIME's 2026 Best Inventions list for Hilo Core, one of the first continuous blood pressure monitors designed for home use.

Hilo Core named one of TIME’s Best Inventions of 2026

21 October 2026

Orbis Medicines, a drug discovery company with operations in Lausanne and Copenhagen, has entered a multi-target collaboration with Novo Nordisk worth up to USD 1.4 billion to develop oral macrocycle drugs for cardiometabolic diseases.

Orbis Medicines and Novo Nordisk partner in a deal worth up to USD 1.4 billion

21 October 2026

Biopôle-based Legacy Healthcare has received Breakthrough Therapy designation from the U.S. FDA for Cinainu, a topical botanical drug for moderate-to-severe alopecia areata in patients aged two and older.

Legacy Healthcare’s botanical treatment receives FDA Breakthrough Therapy designation

21 October 2026

1 2 3 4 5 … 25